2016
DOI: 10.1097/ccm.0000000000002027
|View full text |Cite
|
Sign up to set email alerts
|

Abstract: The Task Force developed a single strong recommendation: we recommend scheduled eye care that includes lubricating drops or gel and eyelid closure for patients receiving continuous infusions of neuromuscular-blocking agents. The Task Force developed 10 weak recommendations. 1) We suggest that a neuromuscular-blocking agent be administered by continuous intravenous infusion early in the course of acute respiratory distress syndrome for patients with a PaO2/FIO2 less than 150. 2) We suggest against the routine a… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

3
222
2
9

Year Published

2016
2016
2021
2021

Publication Types

Select...
4
2

Relationship

0
6

Authors

Journals

citations
Cited by 296 publications
(236 citation statements)
references
References 210 publications
3
222
2
9
Order By: Relevance
“…However, in studies using benzylisoquinoliniums, there was no advantage for amount of infused NMBAs or residual weakness with a TOF compared to a clinical assessment [22, 28]. It is noteworthy that in the 2016 American recommendations, the only indication for NMBAs is ARDS with a ratio PaO2/FiO2 less than 150, and that no dosage and no objective of TOF are advocated [5]. …”
Section: Discussionmentioning
confidence: 99%
See 4 more Smart Citations
“…However, in studies using benzylisoquinoliniums, there was no advantage for amount of infused NMBAs or residual weakness with a TOF compared to a clinical assessment [22, 28]. It is noteworthy that in the 2016 American recommendations, the only indication for NMBAs is ARDS with a ratio PaO2/FiO2 less than 150, and that no dosage and no objective of TOF are advocated [5]. …”
Section: Discussionmentioning
confidence: 99%
“…The previous recommendations of the American and French critical care societies for sustained neuromuscular blockade are of C grade for indications and of B grade for monitoring [2, 4]. In the clinical practice guidelines for sustained neuromuscular blockade in the adult critically ill patient published in 2016 [5], NMBAs are suggested in ARDS patients with a ratio PaO2/FiO2 less than 150 (weak recommendation) but no dosage is mentioned. All these recommendations [2, 4, 5] suggest that in ICU patients the appropriate depth of neuromuscular block may be variable and depends on the reason for neuromuscular blockade, the expected patient outcome, and the phase of the disease.…”
Section: Introductionmentioning
confidence: 99%
See 3 more Smart Citations